RNU6-1102P

Across TCGA pan-cancer cohorts, RNU6-1102P RNA is linked to patient survival in 8 of 34 cancer types, making it the most broadly survival-associated RNU6-1102P data layer.

The strongest signal is observed in kidney chromophobe (KICH), where higher RNU6-1102P RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated RNU6-1102P expression acts as an unfavorable survival marker, although some lineages such as ESCA show a favorable association.

KICH, CESC, and LIHC are the cancer types where RNU6-1102P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KICH	DFS	Tertile	All	0.081	0.904	<.001	90	view →
CESC	OS	Tertile	II,III,IV	0.205	0.764	.007	72	view →
LIHC	OS	Tertile	All	0.173	0.567	<.001	54	view →
KIRC	DFS	Tertile	II,III,IV	0.579	0.781	.022	24	view →
STAD	DFS	Tertile	IV	0.143	0.469	.023	18	view →
PCPG	DFS	Tertile	All	0.097	0.817	<.001	18	view →
ACC	DFS	Tertile	All	0.177	0.672	.020	18	view →
ESCA	OS	Quartile	III,IV	0.604	0.340	.021	8	view →

Pink = unfavorable, green = favorable. Showing the 8 strongest of 8 lineages.

RNU6-1102P–KICH (DFS)

Open the KICH breakdown →